13F
中

DNA GINKGO BIOWORKS HOLDINGS INC

2026Q1 · CUSIP 37611X209 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
172
Δ holders QoQ
-7
Breadth percentile
Top 82%
Whale holders
82
Δ whales
-1
Inst. holding value
$191M
New positions
30
Closed positions
37
Price momentum (1Q)
-18.1%
Put / Call
2/4

Breadth history (34 quarters)

2024Q3: Δ+149 · h=150 2024Q4: Δ+15 · h=165 2025Q1: Δ+1 · h=166 2025Q2: Δ+0 · h=166 2025Q3: Δ+6 · h=172 2025Q4: Δ+7 · h=179 2026Q1: Δ-7 · h=172 2024Q3: holders=150 2024Q4: holders=165 2025Q1: holders=166 2025Q2: holders=166 2025Q3: holders=172 2025Q4: holders=179 2026Q1: holders=172 -149 -74.5 +0 +74.5 +149 135162188 24Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q3 Top 0% +70.9% +8.2%

Options Sentiment

Put holders
2
QoQ: -3
Call holders
4
QoQ: -5

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-5.35
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
-33.4%
Quarterly Revenue & EPS (4Y)
2022-03-31: $168M 2023-09-30: $55M 2024-03-31: $38M 2024-06-30: $56M 2024-09-30: $89M 2024-12-31: $44M 2025-03-31: $38M 2025-06-30: $50M 2025-09-30: $39M 2025-12-31: $43M 2026-03-31: $19M 2022-03-31: EPS -0.01 2023-09-30: EPS -6.21 2024-03-31: EPS -3.32 2024-06-30: EPS -4.23 2024-09-30: EPS -1.08 2024-12-31: EPS -1.91 2025-03-31: EPS -1.68 2025-06-30: EPS -1.10 2025-09-30: EPS -1.45 2025-12-31: EPS -1.41 2026-03-31: EPS -1.39 0M 84M 168M $M -6.83 -3.42 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)